Abstract:During their passage through the circulation, red blood cells (RBCs) encounter severe physiological conditions consisting of mechanical stress, oxidative damage and fast changes in ionic and osmotic conditions. In order to survive for 120 days, RBCs adapt to their surroundings by subtle regulation of membrane organization and metabolism. RBC homeostasis depends on interactions between the integral membrane protein band 3 with other membrane and cytoskeletal proteins, and with key enzymes of various metabolic pathways. These interactions are regulated by the binding of deoxyhemoglobin to band 3, and by a signaling network revolving around Lyn kinase and Src family kinase-mediated phosphorylation of band 3. Here we show that manipulation of the interaction between the lipid bilayer and the cytoskeleton, using various pharmacological agents that interfere with protein-protein interactions and membrane lipid organization, has various effects on: (1) morphology, as shown by high resolution microscopy and quantitative image analysis; (2) organization of membrane proteins, as indicated by immunofluorescence confocal microscopy and quantitative as well as qualitative analysis of vesicle generation; (3) membrane lipid organization, as indicated by flow cytometric analysis of phosphatidylserine exposure; (4) deformability, as assessed in capillary-mimicking circumstances using a microfluidics system; (5) deformability as determined using a spleen-mimicking device; (6) metabolic activity as indicated by metabolomics. Our data show that there is a complex relationship between red cell morphology, membrane organization and deformability. Also, our data show that red blood cells have a relatively high resistance to disturbance of membrane organization in vitro, which may reflect their capacity to withstand mechanical, oxidative and osmotic stress in vivo.

Molecular mechanism for the red blood cell senescence clock

Mechanisms tagging senescent red blood cells for clearance in healthy humans

How Do Red Blood Cells Die?

Erythrocyte Membrane Changes during Aging in Vivo

Reduced PKC α Activity Induces Senescent Phenotype in Erythrocytes

Cellular senescence and the blood–brain barrier: Implications for aging and age-related diseases

Cellular senescence: the good, the bad and the unknown

Single cell RNA sequencing unravels mechanisms underlying senescence-like phenotypes of Alveolar Macrophages

Bcl-xL as a Modulator of Senescence and Aging

Macrophage Senescence in Health and Diseases

Aging‐associated changes in CD47 arrangement and interaction with thrombospondin‐1 on red blood cells visualized by super‐resolution imaging

CD47 on experimentally senescent murine RBCs inhibits phagocytosis following Fcgamma receptor-mediated but not scavenger receptor-mediated recognition by macrophages

Impaired immune surveillance accelerates accumulation of senescent cells and aging

Mechanisms and Regulation of Cellular Senescence

Continuous Change in Membrane and Membrane-Skeleton Organization During Development From Proerythroblast to Senescent Red Blood Cell

Quantifiable blood TCR repertoire components associate with immune aging

Red Blood Cell Homeostasis: Pharmacological Interventions to Explore Biochemical, Morphological and Mechanical Properties

Senescent Cells: Emerging Targets for Human Aging and Age-Related Diseases

Zom-biecoming: Single-Cell RNA-seq reveals senescence-like features of alveolar macrophages during aging

Biomechanics of phagocytosis of red blood cells by macrophages in the human spleen

Cellular senescence impact on immune cell fate and function